|
|
|
|
Science Sparks @ ACTREC
|
 26 January 2026 |
Vol. No. 15 ; Issue No.719 |
|
|
Publications
|
|
1. Bhandare MS, Nandy K, Parray AM, Pawar A, Padhy A, Menon V, Chopde A, Chaudhari V, Shrikhande SV (2026). Interplay of Post-Pancreatectomy Acute Pancreatitis, Postoperative Pancreatic Fistula, and Mortality after Pancreatoduodenectomy: Insights from a Comprehensive Cohort Study of 1594 Patients and Development of Predictive Nomograms. Journal of the American College of Surgeons.
2. Dhar A, Siva S, Tan VS, Mahadevan A, Bruynzeel A, Tang C, Cury F, Corkum M, Ali M, Zaorsky NG, Cheung P, Hannan R, Hudes R, Morgan S, Lo S, Murthy V, Correa RJM, Swaminath A (2026). International Radiosurgery Oncology Consortium of the Kidney (IROCK) contouring guidelines for renal cell carcinoma treated with stereotactic ablative radiotherapy. International Journal of Radiation Oncology, Biology, Physics.
Thesis
Tejashree Satish Mahaddalkar. 2025. Understanding the Molecular Mechanism of Therapy Resistance in Glioblastoma Using Preclinical Orthotopic Mouse Model. (LIFE09201704017) (Guide: Dr. Manoj Mahimkar)
|
|
|
|
|
Interesting Reads
|
|
van Haften FJ, van der Sluis TC, Hepp HS, Mülling N, Nadafi R, Sampadi B, van Duikeren S, Mostert JS, van der Sterre R, van Veelen PA, Heieis GA, Veerkamp DMB, Wesselink TH, Vleeshouwers W, Beijnes M, Pardieck IN, van Horssen ELF, de Groot AF, van der Ploeg M, Kroep JR, de Miranda NFCC, van der Zanden SY, Neefjes J, Mei H, Vertegaal ACO, Everts B, van der Burg SH, Arens R (2026). Cell cycle arrest enhances CD8+ T cell effector function by potentiating glucose metabolism and IL-2 signaling. Nature Immunology.
|
|
|
Video of the Week
|
|
| Clinical Application of Genomics for Childhood Cancer Patients An Update |
|
| |
|
|
| |
|
|
|
|
Do You Know?
In, 2018, FDA approves larotrectinib, the first drug that targets tumors with NTRK gene fusions.
|
|
|
|
Cancer News
|
| |
|
|
| |
|
|
|
Discovery illuminates how inflammatory bowel disease promotes colorectal cancer.
|
|
Eurekalert, 22/01/2026
|
|
Neutrophils can promote colorectal tumors by secreting highly reactive molecules that can damage DNA in gut-lining cells. However, the team found that the gut ILC3s also induce a distinctive pattern of gene activity in the neutrophils including increased expressions of genes known to promote tumor...
|
|
|
|
|
|
|
|
|
2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|
